Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial

Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial

Background: Negative symptoms of schizophrenia represent deficiencies in emotional responsiveness, motivation, socialisation, speech and movement. When persistent, they are held to account for much of the poor functional outcomes associated with schizophrenia. There are currently no approved pharmac...

ver descrição completa

Detalhes bibliográficos
Principais autores: Thomas RE Barnes, Verity C Leeson, Carol Paton, Céire Costelloe, Judit Simon, Noemi Kiss, David Osborn, Helen Killaspy, Tom KJ Craig, Shôn Lewis, Patrick Keown, Shajahan Ismail, Mike Crawford, David Baldwin, Glyn Lewis, John Geddes, Manoj Kumar, Rudresh Pathak, Simon Taylor
Formato: Artigo
Idioma:English
Publicado em: NIHR Journals Library 2016-04-01
coleção:Health Technology Assessment
Assuntos:
citalopram
antipsychotic
schizophrenia
negative symptoms
randomised controlled trial
ssri antidepressant
antipsychotic augmentation
Acesso em linha:https://doi.org/10.3310/hta20290

Internet

https://doi.org/10.3310/hta20290

Registros relacionados